The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
| Saunders and Walker

According to an article published in the Journal of the American Medical Association older people who suffer from diabetes and take Avandia as part of their treatment regimen are 60% increased risk of heart failure, a 40% increased risk of heart attack, and a 30% increased risk of death. This is obviously not good news for Glaxo Smith Kline, the manufacturer of Avandia. Avandia is a controversial drug designed to treat Type II diabetes but has faced stiff criticism concerning its links to cardiac issues.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.